by Zachary | Feb 27, 2025 | Emerging Trends
Miley Nguyen, PharmD & Navya Brinda African American Health Disparities & Pharmacogenomics. How can pharmacogenomics (PGx) address health disparities in the African American population? African Americans face significant health disparities resulting from...
by Zachary | Feb 19, 2025 | Emerging Trends
Raymond A. Lorenz, PharmD, BCPP & Jeffrey Mando, B.S Tailored Treatment of Cystic Fibrosis through Pharmacogenomics. Does pharmacogenomics (PGx) offer a path towards more effective cystic fibrosis (CF) treatment? Cystic Fibrosis (CF) is an autosomal recessive...
by Zachary | Feb 12, 2025 | Emerging Trends
Raymond A. Lorenz, PharmD, BCPP & Niharika Koppulu Pharmacogenomics-Enriched Comprehensive Medication Management: A Retrospective Cohort Study. Did you know over 99% of patients have genetic variations impacting their response to drugs (Chanfreau-Coffinier, et al....
by Zachary | Feb 4, 2025 | Emerging Trends
Husna Rahim, PharmD & Jayden Lee, EMBA, PharmD, BCACP Exploring the Role of Nutrigenetics in Personalized Care. How can the field of nutrigenetics revolutionize our approach to individualized healthcare? The relationship between genetics and nutrition is an...
by Zachary | Jan 29, 2025 | Emerging Trends
Miley Nguyen, PharmD & Niharika Koppolu Preeclampsia Management in Pregnancy: The Role of Pharmacogenomics. Can clinicians leverage genetic testing to effectively manage pre-eclampsia in pregnant patients? Recent findings suggest the answer is yes. Pre-eclampsia,...
by Zachary | Jan 23, 2025 | Emerging Trends
Raymond A. Lorenz, PharmD, BCPP & Zachary S. Brooks, PhD Pharmacogenomics in Chronic Kidney Disease. What do the genetics of a patient with chronic kidney disease (CKD) have to do with which medications they may respond to? As it turns out, quite a lot! Patients...
